Cassava Sciences | PTIE - Capitalisation Boursière





Capitalisation Boursière Changement Date
Abbott USD 168.02B 10.39B 2026-04
Amgen USD 176.25B 24.32B 2025-12
Biogen USD 25.82B 5.28B 2025-12
Cara Therapeutics USD 366M 338M 2025-09
Cassava Sciences USD 96M 45M 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Geron USD 843M 31M 2025-12
J&J USD 561.65B 17.5B 2026-04
Merck USD 261.26B 51.62B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Novavax USD 1.09B 316M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12